MedPath

A study to determine effective dose of dexmedetomidine when added to ropivacaine to produce efficient ultrasound guided supraclavicular brachial plexus block in surgeries of arm

Not Applicable
Completed
Conditions
Health Condition 1: M80-M85- Disorders of bone density and structure
Registration Number
CTRI/2020/02/023167
Lead Sponsor
P Akshara
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients undergoing elective upper limb surgeries

American Society of Anaesthesiologist I or II

Exclusion Criteria

Patient refusal

Patients with pre existing peripheral neuropathy of upper limb

Patients allergic to local anesthetics

Patients on adrenoreceptor agonist/ antagonist therapy

American Society of Anaesthesiologist III and above Patients with coagulation disorders

Local site infection

BMI above 30

Poorly controlled Hypertension

Poorly controlled Diabetes mellitus

Severe CVS abnormalities

Renal/Hepatic insufficiency

Pregnancy/ Lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare duration of analgesia of two different doses of dexmedetomidine in terms of first rescue analgesia requirementTimepoint: Post operative period
Secondary Outcome Measures
NameTimeMethod
Onset and duration of sensorimotor blockade <br/ ><br>Peri operative analgesic requirements <br/ ><br>Sedation <br/ ><br>Hemodynamic stabilityTimepoint: Peri operative Period
© Copyright 2025. All Rights Reserved by MedPath